ctrl K

Watchlist Price Alert

Nabriva Therapeutics (NBRV)

NASDAQ: NBRV · Real-Time Price · USD

1.42

0.01 (0.71%)

At close: Jul 31, 2023, 8:00 PM

Nabriva Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	35.67M	27.22M	2.86M	7.75M	6.5M	n/a	n/a
Cost of Revenue	28.58M	13.15M	766K	70K	n/a	n/a	n/a
Gross Profit	7.09M	14.07M	2.1M	7.68M	6.5M	n/a	n/a
Operating Income	-51.17M	-48.53M	-66.13M	-79.49M	-114.38M	-73.77M	-55.05M
Interest Income	n/a	n/a	86K	255K	49K	318K	343K
Pretax Income	-55.62M	-48.96M	-69.34M	-82.66M	-114.73M	-73M	-55.56M
Net Income	-57.19M	-49.45M	-69.48M	-82.76M	-114.78M	-74.36M	-54.89M
Selling & General & Admin	45.26M	51.65M	55.28M	62.48M	41.74M	29.47M	13.44M
Research & Development	14.26M	12.63M	15.1M	26.41M	82.29M	49.62M	47.99M
Other Expenses	-1.27M	-1.68M	-2.16M	-1.73M	-272K	492K	55K
Operating Expenses	58.26M	62.6M	68.22M	87.17M	120.88M	73.77M	55.05M
Interest Expense	698K	n/a	1.74M	3.64M	133K	43K	75K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	86.84M	75.74M	68.99M	87.24M	120.88M	73.77M	55.05M
Income Tax Expense	1.57M	490K	139K	101K	49K	1.35M	-672K
Shares Outstanding (Basic)	2.68M	1.73M	513.8K	296.8K	203.18K	119.32K	85.91K
Shares Outstanding (Diluted)	2.68M	1.73M	513.8K	296.8K	203.18K	119.32K	85.91K
EPS (Basic)	-21.32	-28.52	-135.23	-278.86	-564.91	-623.15	-638.9
EPS (Diluted)	-21.32	-28.52	-135.23	-278.86	-564.91	-623.15	-638.9
EBITDA	-54.7M	-48.53M	-64.85M	-79.02M	-114.09M	-72.53M	-54.42M
EBIT	-50.6M	-49.86M	-67.61M	-79.02M	-114.6M	-72.96M	-55.49M
Depreciation & Amortization	-3.53M	637K	1.27M	470K	510K	432K	233K